{"id":13364,"date":"2025-09-10T17:27:14","date_gmt":"2025-09-10T17:27:14","guid":{"rendered":"https:\/\/latamreports.com\/br\/?p=13364"},"modified":"2025-09-10T17:27:16","modified_gmt":"2025-09-10T17:27:16","slug":"novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic","status":"publish","type":"post","link":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/","title":{"rendered":"Novo Nordisk anuncia corte de 9 mil funcion\u00e1rios em meio \u00e0 concorr\u00eancia do Ozempic"},"content":{"rendered":"\n<p>A <a href=\"https:\/\/latamreports.com\/br\/venda-de-ozempic-e-similares-passa-a-exigir-retencao-de-receita-especialistas-alertam-para-uso-abusivo\/\">Novo Nordisk<\/a>, fabricante do Ozempic e do Wegovy, anunciou nesta quarta-feira, 10, que vai demitir 9 mil funcion\u00e1rios. O corte representa 11% da for\u00e7a de trabalho global da empresa. A medida busca reduzir custos diante da forte concorr\u00eancia no mercado de medicamentos para obesidade e diabetes.<\/p>\n\n\n\n<p>Segundo comunicado, a decis\u00e3o deve gerar economia de 8 bilh\u00f5es de coroas dinamarquesas (cerca de US$ 1,3 bilh\u00e3o ou R$ 7 bilh\u00f5es) at\u00e9 2026. S\u00f3 na Dinamarca, sede da farmac\u00eautica, cinco mil postos de trabalho ser\u00e3o eliminados.<\/p>\n\n\n\n<p>A companhia tamb\u00e9m revisou suas proje\u00e7\u00f5es de lucro para 2025 pela terceira vez no ano. Agora, espera crescimento entre 4% e 10%. Antes, a previs\u00e3o era de at\u00e9 16%.<\/p>\n\n\n\n<p>O CEO Mike Doustdar afirmou que os cortes fazem parte de uma \u201ctransforma\u00e7\u00e3o global\u201d para simplificar a estrutura. \u201cO mercado mudou, especialmente o da obesidade, que ficou mais competitivo e voltado ao consumidor. Precisamos acompanhar essa evolu\u00e7\u00e3o\u201d, disse o executivo.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">De expans\u00e3o acelerada a queda nas a\u00e7\u00f5es<\/h2>\n\n\n\n<p>O sucesso das inje\u00e7\u00f5es contra obesidade transformou a Novo Nordisk na empresa mais valiosa da Europa. O quadro de funcion\u00e1rios saltou de 43,7 mil em 2020 para 78,4 mil em 2024. A expans\u00e3o, no entanto, n\u00e3o resistiu \u00e0 queda recente nas vendas e \u00e0 valoriza\u00e7\u00e3o menor das a\u00e7\u00f5es.<\/p>\n\n\n\n<p>A principal rival \u00e9 a farmac\u00eautica americana Eli Lilly, que tamb\u00e9m lan\u00e7ou tratamentos baseados no <a href=\"https:\/\/latamreports.com\/br\/eduardo-paes-promete-forca-de-seguranca-armada-e-ozempic-no-rio\/\">horm\u00f4nio GLP-1. <\/a>Al\u00e9m disso, a capacidade limitada de produ\u00e7\u00e3o levou farm\u00e1cias dos Estados Unidos a venderem vers\u00f5es \u201ccompostas\u201d do Ozempic e do Wegovy.<\/p>\n\n\n\n<p>Embora a autoriza\u00e7\u00e3o emergencial da FDA tenha terminado em maio, a Novo Nordisk afirma que gen\u00e9ricos seguem sendo comercializados sob a justificativa de \u201cpersonaliza\u00e7\u00e3o\u201d.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">O impacto do Ozempic e do Wegovy<\/h2>\n\n\n\n<p>O Ozempic \u00e9 indicado para diabetes, mas ganhou fama mundial ap\u00f3s relatos de perda de peso. J\u00e1 o Wegovy, com dose diferente do mesmo princ\u00edpio ativo, \u00e9 prescrito especificamente para obesidade. Ambos atuam sobre o horm\u00f4nio GLP-1, que regula glicose e apetite.<\/p>\n\n\n\n<p>O futuro da empresa depender\u00e1 da capacidade de manter espa\u00e7o em um mercado cada vez mais competitivo e de combater a prolifera\u00e7\u00e3o de c\u00f3pias ilegais de seus medicamentos.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Novo Nordisk, fabricante do Ozempic e do Wegovy, anunciou nesta quarta-feira, 10, que vai demitir 9 mil funcion\u00e1rios. O corte representa 11% da for\u00e7a &#8230; <a title=\"Novo Nordisk anuncia corte de 9 mil funcion\u00e1rios em meio \u00e0 concorr\u00eancia do Ozempic\" class=\"read-more\" href=\"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/\" aria-label=\"Read more about Novo Nordisk anuncia corte de 9 mil funcion\u00e1rios em meio \u00e0 concorr\u00eancia do Ozempic\">Read more<\/a><\/p>\n","protected":false},"author":7,"featured_media":13365,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[2],"tags":[31],"class_list":["post-13364","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-negocios","tag-brasil","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Empresa do Ozempic anuncia corte 9 de mil funcion\u00e1rios<\/title>\n<meta name=\"description\" content=\"A Novo Nordisk, fabricante do Ozempic e do Wegovy, anunciou nesta quarta-feira, 10, que vai demitir 9 mil funcion\u00e1rios.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Empresa do Ozempic anuncia corte 9 de mil funcion\u00e1rios\" \/>\n<meta property=\"og:description\" content=\"A Novo Nordisk, fabricante do Ozempic e do Wegovy, anunciou nesta quarta-feira, 10, que vai demitir 9 mil funcion\u00e1rios.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/\" \/>\n<meta property=\"og:site_name\" content=\"LatAm Reports\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/latamreports\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-10T17:27:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-10T17:27:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/latamreports.com\/br\/wp-content\/uploads\/novo-nordisk-ozempic.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"LatAm Reports Redatores da Equipe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@latamreports\" \/>\n<meta name=\"twitter:site\" content=\"@latamreports\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"LatAm Reports Redatores da Equipe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/\"},\"author\":{\"name\":\"LatAm Reports Redatores da Equipe\",\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/#\\\/schema\\\/person\\\/a561f2de7e5ccabfab38d239b39fdb70\"},\"headline\":\"Novo Nordisk anuncia corte de 9 mil funcion\u00e1rios em meio \u00e0 concorr\u00eancia do Ozempic\",\"datePublished\":\"2025-09-10T17:27:14+00:00\",\"dateModified\":\"2025-09-10T17:27:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/\"},\"wordCount\":380,\"publisher\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/latamreports.com\\\/br\\\/wp-content\\\/uploads\\\/novo-nordisk-ozempic.png\",\"keywords\":[\"Brasil\"],\"articleSection\":[\"Neg\u00f3cios\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/\",\"url\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/\",\"name\":\"Empresa do Ozempic anuncia corte 9 de mil funcion\u00e1rios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/latamreports.com\\\/br\\\/wp-content\\\/uploads\\\/novo-nordisk-ozempic.png\",\"datePublished\":\"2025-09-10T17:27:14+00:00\",\"dateModified\":\"2025-09-10T17:27:16+00:00\",\"description\":\"A Novo Nordisk, fabricante do Ozempic e do Wegovy, anunciou nesta quarta-feira, 10, que vai demitir 9 mil funcion\u00e1rios.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/latamreports.com\\\/br\\\/wp-content\\\/uploads\\\/novo-nordisk-ozempic.png\",\"contentUrl\":\"https:\\\/\\\/latamreports.com\\\/br\\\/wp-content\\\/uploads\\\/novo-nordisk-ozempic.png\",\"width\":1200,\"height\":630,\"caption\":\"Novo Nordisk anuncia corte de 9 mil funcion\u00e1rios em meio \u00e0 concorr\u00eancia do Ozempic\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/latamreports.com\\\/br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo Nordisk anuncia corte de 9 mil funcion\u00e1rios em meio \u00e0 concorr\u00eancia do Ozempic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/#website\",\"url\":\"https:\\\/\\\/latamreports.com\\\/br\\\/\",\"name\":\"LatAm Reports\",\"description\":\"Not\u00edcias e opini\u00f5es de todas as Am\u00e9ricas\",\"publisher\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/latamreports.com\\\/br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/#organization\",\"name\":\"LatAm Reports\",\"url\":\"https:\\\/\\\/latamreports.com\\\/br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/latamreports.com\\\/br\\\/wp-content\\\/uploads\\\/cropped-PNG2.png\",\"contentUrl\":\"https:\\\/\\\/latamreports.com\\\/br\\\/wp-content\\\/uploads\\\/cropped-PNG2.png\",\"width\":2522,\"height\":1014,\"caption\":\"LatAm Reports\"},\"image\":{\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/facebook.com\\\/latamreports\",\"https:\\\/\\\/x.com\\\/latamreports\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/latamreports.com\\\/br\\\/#\\\/schema\\\/person\\\/a561f2de7e5ccabfab38d239b39fdb70\",\"name\":\"LatAm Reports Redatores da Equipe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dcdcc93cc5edddd2f3ef77245866172c7d7241a11ad58e1959aa824f2fae81f6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dcdcc93cc5edddd2f3ef77245866172c7d7241a11ad58e1959aa824f2fae81f6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dcdcc93cc5edddd2f3ef77245866172c7d7241a11ad58e1959aa824f2fae81f6?s=96&d=mm&r=g\",\"caption\":\"LatAm Reports Redatores da Equipe\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Empresa do Ozempic anuncia corte 9 de mil funcion\u00e1rios","description":"A Novo Nordisk, fabricante do Ozempic e do Wegovy, anunciou nesta quarta-feira, 10, que vai demitir 9 mil funcion\u00e1rios.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/","og_locale":"en_US","og_type":"article","og_title":"Empresa do Ozempic anuncia corte 9 de mil funcion\u00e1rios","og_description":"A Novo Nordisk, fabricante do Ozempic e do Wegovy, anunciou nesta quarta-feira, 10, que vai demitir 9 mil funcion\u00e1rios.","og_url":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/","og_site_name":"LatAm Reports","article_publisher":"https:\/\/facebook.com\/latamreports","article_published_time":"2025-09-10T17:27:14+00:00","article_modified_time":"2025-09-10T17:27:16+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/latamreports.com\/br\/wp-content\/uploads\/novo-nordisk-ozempic.png","type":"image\/png"}],"author":"LatAm Reports Redatores da Equipe","twitter_card":"summary_large_image","twitter_creator":"@latamreports","twitter_site":"@latamreports","twitter_misc":{"Written by":"LatAm Reports Redatores da Equipe","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/#article","isPartOf":{"@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/"},"author":{"name":"LatAm Reports Redatores da Equipe","@id":"https:\/\/latamreports.com\/br\/#\/schema\/person\/a561f2de7e5ccabfab38d239b39fdb70"},"headline":"Novo Nordisk anuncia corte de 9 mil funcion\u00e1rios em meio \u00e0 concorr\u00eancia do Ozempic","datePublished":"2025-09-10T17:27:14+00:00","dateModified":"2025-09-10T17:27:16+00:00","mainEntityOfPage":{"@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/"},"wordCount":380,"publisher":{"@id":"https:\/\/latamreports.com\/br\/#organization"},"image":{"@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/#primaryimage"},"thumbnailUrl":"https:\/\/latamreports.com\/br\/wp-content\/uploads\/novo-nordisk-ozempic.png","keywords":["Brasil"],"articleSection":["Neg\u00f3cios"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/","url":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/","name":"Empresa do Ozempic anuncia corte 9 de mil funcion\u00e1rios","isPartOf":{"@id":"https:\/\/latamreports.com\/br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/#primaryimage"},"image":{"@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/#primaryimage"},"thumbnailUrl":"https:\/\/latamreports.com\/br\/wp-content\/uploads\/novo-nordisk-ozempic.png","datePublished":"2025-09-10T17:27:14+00:00","dateModified":"2025-09-10T17:27:16+00:00","description":"A Novo Nordisk, fabricante do Ozempic e do Wegovy, anunciou nesta quarta-feira, 10, que vai demitir 9 mil funcion\u00e1rios.","breadcrumb":{"@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/#primaryimage","url":"https:\/\/latamreports.com\/br\/wp-content\/uploads\/novo-nordisk-ozempic.png","contentUrl":"https:\/\/latamreports.com\/br\/wp-content\/uploads\/novo-nordisk-ozempic.png","width":1200,"height":630,"caption":"Novo Nordisk anuncia corte de 9 mil funcion\u00e1rios em meio \u00e0 concorr\u00eancia do Ozempic"},{"@type":"BreadcrumbList","@id":"https:\/\/latamreports.com\/br\/novo-nordisk-anuncia-corte-de-9-mil-funcionarios-em-meio-a-concorrencia-do-ozempic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/latamreports.com\/br\/"},{"@type":"ListItem","position":2,"name":"Novo Nordisk anuncia corte de 9 mil funcion\u00e1rios em meio \u00e0 concorr\u00eancia do Ozempic"}]},{"@type":"WebSite","@id":"https:\/\/latamreports.com\/br\/#website","url":"https:\/\/latamreports.com\/br\/","name":"LatAm Reports","description":"Not\u00edcias e opini\u00f5es de todas as Am\u00e9ricas","publisher":{"@id":"https:\/\/latamreports.com\/br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/latamreports.com\/br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/latamreports.com\/br\/#organization","name":"LatAm Reports","url":"https:\/\/latamreports.com\/br\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/latamreports.com\/br\/#\/schema\/logo\/image\/","url":"https:\/\/latamreports.com\/br\/wp-content\/uploads\/cropped-PNG2.png","contentUrl":"https:\/\/latamreports.com\/br\/wp-content\/uploads\/cropped-PNG2.png","width":2522,"height":1014,"caption":"LatAm Reports"},"image":{"@id":"https:\/\/latamreports.com\/br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/latamreports","https:\/\/x.com\/latamreports"]},{"@type":"Person","@id":"https:\/\/latamreports.com\/br\/#\/schema\/person\/a561f2de7e5ccabfab38d239b39fdb70","name":"LatAm Reports Redatores da Equipe","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/dcdcc93cc5edddd2f3ef77245866172c7d7241a11ad58e1959aa824f2fae81f6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/dcdcc93cc5edddd2f3ef77245866172c7d7241a11ad58e1959aa824f2fae81f6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dcdcc93cc5edddd2f3ef77245866172c7d7241a11ad58e1959aa824f2fae81f6?s=96&d=mm&r=g","caption":"LatAm Reports Redatores da Equipe"}}]}},"jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/posts\/13364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/comments?post=13364"}],"version-history":[{"count":2,"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/posts\/13364\/revisions"}],"predecessor-version":[{"id":13367,"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/posts\/13364\/revisions\/13367"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/media\/13365"}],"wp:attachment":[{"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/media?parent=13364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/categories?post=13364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/latamreports.com\/br\/wp-json\/wp\/v2\/tags?post=13364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}